ClinicalTrials.gg
CompletedNCT03361761EDUPACTUpdated Sep 19, 2024

Impact of a Therapeutic Education Program on the Acceptance of Disease and Management of Care

An observational study in Chronic Disease, sponsored by Nantes University Hospital. Completed at 6 sites in France. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Primary conditionChronic Disease(the registry's first term)UnverifiedIs this wrong?Chronic Disease is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Nantes University Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
66
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Through its patient-centered approach and focus on developing coping skills and coping strategies, Health Education could be an effective approach in therapeutic coordination apartments to reduce the perceived treatment burden among people in precarious situations with one or more chronic diseases. Decreasing perception of burden would improve their quality of life and adherence to treatment.

The general hypothesis explored in this project is that the experience of the disease, the perception of the burden of treatment, the autonomy and the quality of life of the residents improve more importantly in therapeutic coordination apartments having implemented a formalized and structured Health Education approach (experimental group) than in those who did not set up formalized and structured Health Education approach (control group).

Read the detailed description

Context: The significant increase in the number of patients with chronic disease in France in recent years has led to the implementation of therapeutic patient education programs to develop their independence and quality of life in regard to their illness. Despite this growth, socio-economic status, cultural level or education still remain significant obstacles to access to Health education for patients with psychosocial vulnerability. In this context, the implementation of an Health education approach in specific living devices called therapeutic coordination apartments (TCA) was tested in 2011. The TCAs are medico-social establishments offering accommodation and temporary medical-psycho-social support to people in a situation of precariousness affected by at least one disabling chronic pathology in order to restore their autonomy. However, only two TCAs currently offer Health Education programs integrated with their activities. These two structures were supported by the Transverse Unit for Therapeutic Education (UTET) of the University Hospital of Nantes for the construction of these programs, now authorized by the Regional Health Agency of the Pays de la Loire and effective for 18 months.

Objective: The overall objective of the project is to evaluate the added value of integrated Health Education in TCA care. The main objective will be to compare, at 6 months of care, the perception of the burden of treatment among TCA residents integrating the practice of Health Education versus control group TCA residents. The burden of treatment is defined as the perception of the constraints on daily life related to all of what a person does to heal. The secondary objectives will be, on the one hand, to evaluate the impact of Health Education in TCA on: the state of health of the residents and the perception of their state of health, their quality of life and their empowerment. On the other hand, they will study the benefits, the brakes and the levers perceived by the teams that have integrated the Health Education in their activity.

METHOD: This is a pragmatic, controlled, quasi-experimental intervention trial comparing two groups of residents: one experimental group in two TCAs incorporating Health Education and one group of 4 control TCAs. The study will be mixed, qualitative and quantitative with residents and professionals. All new volunteer residents entering TCA for 1 year will be solicited (approximately 5 to 15 per TCA). The burden of treatment will be assessed for each group after 1 month in TCA (baseline) and then at 6 months by the Treatment Burden Questionnaire. The secondary criteria will be explored quantitatively at 1 month, 6 months and 12-18 months by the EQ-5D questionnaire, the 2 global items of the WHO-QOL Brief and the MAP13, as well as the count of hospitalizations and Resident emergencies, in relation to their chronic pathology. A qualitative survey consisting of individual interviews with residents and focus groups with Therapeutic Coordination Apartments' teams practicing Health Education. The total duration of the study is 36 months.

Perspectives: By showing a potential added value for the residents of the integration of Health Education within the TCAs, this project will confirm the interest to cross specific practices of care in TCA (adapted to the precarious people, having a low level of health literacy) with Health Education practices tailored to people with multiple pathologies. The study of the perceptions of teams integrating Health Education into their practice may encourage the diffusion of these still rare programs in these structures.

02

Conditions studied

  • Chronic Disease

Browse trials for

Keywords

  • Chronic disease
  • precariousness and vulnerability
  • Health education
03

In context

Chronic Disease Unverified

781 studies on the registry are indexed under Chronic Disease; 144 are open to participants now.

This study's enrollment of 66 is below the median of 461 across 188 observational studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 839 studies on the registry; 195 are open to participants now.

Compared within Chronic Disease, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study focuses on patients in a precarious situation with chronic pathology (one or more) that are admitted in a Therapeutic Coordination Apartment (TCA). TCA's residents are women or men, French or coming from abroad, needing medical-social welfare support to manage their disease, treatments, everyday life, and approaches.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • residents admitted in therapeutic coordination apartments since October 2017;
  • with one or more chronic disease
  • over 18
  • accepting being enrolled in the study

Exclusion criteria

Exclusion Criteria:

  • residents in situation of great psychological and / or physical suffering
  • Residents with diseases incompatible with questionnaires (cognitive disorders, impaired comprehension or severe speech disorder)
  • Residents non-francophone without interpreter
  • Residents under justice protective measure
  • Investigator declining the participation of a resident for any substantial reason
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
66 participants (actual)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • experimental

    therapeutic coordination apartments with formalized/official Health education program

    Other: Health education program

  • active comparator

    therapeutic coordination apartments without formalized/official Health education program

    Other: Health education program

Interventions

  • OtherHealth education program

    formalized/official Health education program

  • OtherHealth education program

    non formalized/official Health education program

06

What researchers measure

Primary outcomes

  1. evaluation of the impact of a formal approach to therapeutic patient education on the intensity of the treatment burden perceived by residents compared to therapeutic coordination apartment residents not benefiting from an authorized program

    The Baseline assessment and the 6 months assessment of Treatment burden score (assessed with TBQ:Treatment burden survey)

    Time frame: 6 months after the enrolment in the study

Secondary outcomes

  1. impact of therapeutic patient education on residents' level of depression

    comparison between assessments at baseline and after 6 months - (self-assessed by residents with Hospital Anxiety and Depression scale :HAD scale)

    Time frame: 6 months after the enrolment in the study

  2. impact of therapeutic patient education on residents' health status

    comparison between assessments at baseline and after 6 months - (assessed with number of admission in emergency unit, number of hospitalizations)

    Time frame: 6 months after the enrolment in the study

  3. impact of therapeutic patient education on residents' empowerment level

    comparison between assessments at baseline and after 6 months - (self-assessed by residents with Patient Actvation Measure survey (MAP13))

    Time frame: 6 months after the enrolment in the study

  4. impact of therapeutic patient education on residents' perception of health status

    comparison between assessments at baseline and after 6 months - (self-assessed by residents with The World Healyh Organisation Quality of Life survey (WHO-QoL))

    Time frame: 6 months after the enrolment in the study

  5. impact of therapeutic patient education on residents' quality of life

    comparison between assessments at baseline and after 6 months - (self-assessed by residents with Euroqol 5 dimensions survey (EQ-5D))

    Time frame: 6 months after the enrolment in the study

07

Study locations

6 sites
  • Act Passerelle
    La Roche-sur-Yon, 85000, France
  • Act Acothe
    Le Mans, 72100, France
  • Act Aurore
    Nantes, 44000, France
  • CHU de Nantes
    Nantes, 44093, France
  • ACT Le Logis Montjoie
    Nantes, 44300, France
  • ACT Louis Guilloux
    Rennes, 35200, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2018 to primary completion in Dec 2021, 46 months.

Of 86 non-industry observational studies under Chronic Disease, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 53. This study's 46 months is above that.

Counting every sponsor, half of 91 studies reached it within 37 months; a quarter within 14.

Chronic Disease covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2017
First posted
Dec 5, 2017
StartActual
Jan 25, 2018
Primary completionActual
Dec 10, 2021
CompletionActual
Dec 10, 2021
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03361761
Collaborators
Institut de Recherche en Santé Publique, France
Responsible party
Sponsor
First posted
Dec 5, 2017
Start date
Jan 25, 2018
Primary completion
Dec 10, 2021
Completion
Dec 10, 2021
Last update
Sep 19, 2024

Study contacts

Clément Le Glatin, PH
principal investigator · Nantes University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion